Hapbee Announces Closing of Private Placement
April 24, 2024 16:33 ET
|
Hapbee Technologies, Inc.
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company...
Surge Copper Announces Closing of Private Placement for $1.0 million
April 24, 2024 16:30 ET
|
Surge Copper Corp.
Vancouver, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) announces that it has closed its...
Entourage Health to Report Fiscal Year 2023 Financial Results
April 24, 2024 16:16 ET
|
Entourage Health Corp.
TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
April 24, 2024 16:05 ET
|
QIAGEN N.V.
Venlo, the Netherlands, April 24, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for...
QIAGEN erweitert Tuberkulose-Portfolio: Neues NGS-Panel unterstützt Echtzeit-Überwachung und Bekämpfung antimikrobieller Resistenzen
April 24, 2024 16:05 ET
|
QIAGEN N.V.
VENLO, Niederlande, April 24, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung des QIAseq xHYB Mycobacterium tuberculosis Panel zu...
Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats
April 24, 2024 12:00 ET
|
Basilea Pharmaceutica AG
Allschwil, 24. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
April 24, 2024 12:00 ET
|
Basilea Pharmaceutica AG
Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Canadian North Resources Inc. Reports Operational and Financial Results for the Year Ended December 31, 2023
April 24, 2024 11:24 ET
|
Canadian North Resources Inc.
2023 Operational and Project Highlights: The Company raised over $17 million for exploration, with cash and cash equivalents of $5,540,312 at the year end Completed aggressive exploration programs...
Xtract One Closes $7.2M Public Offering and $1.4M Investment by Strategic Partner
April 24, 2024 10:32 ET
|
Xtract One Technologies Inc.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, April 24, 2024 ...
Class 1 Nickel Updates Resource Estimate on High-Grade Alexo South Nickel Sulphide Deposit – Significant Increases in Indicated and Inferred Resources Over the 2020 Estimate
April 24, 2024 10:31 ET
|
Class 1 Nickel and Technologies Limited
Indicated Resources (open pit and underground*) of 572 kt at 0.61% Ni (7.7M lbs Ni) – 44% increase in Indicated tonnes and 10% increase in nickel pounds.Inferred Resources (open pit and underground*)...